Published in J Neurol Sci on March 15, 2001
Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging (2009) 1.70
Cognitive presentation of multiple sclerosis: evidence for a cortical variant. J Neurol Neurosurg Psychiatry (2003) 1.11
Iron and neurodegeneration in multiple sclerosis. Mult Scler Int (2011) 1.07
Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx (2005) 0.98
Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol (2005) 0.96
Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol (2012) 0.94
MRI in rodent models of brain disorders. Neurotherapeutics (2011) 0.94
Deep gray matter T2 hypointensity correlates with disability in a murine model of MS. J Neurol Sci (2009) 0.91
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model. Neurobiol Aging (2008) 0.89
Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis. Hum Genet (2004) 0.89
Visualizing iron in multiple sclerosis. Magn Reson Imaging (2013) 0.89
Multiple sclerosis: a white matter disease with associated gray matter damage. J Neurol Sci (2001) 0.83
Neuroradiological evaluation of demyelinating disease. Ther Adv Neurol Disord (2013) 0.80
Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis. PLoS One (2015) 0.78
Vascular pathology in multiple sclerosis: mind boosting or myth busting? Exp Transl Stroke Med (2011) 0.76
Relationship between iron accumulation and white matter injury in multiple sclerosis: a case-control study. J Neurol (2014) 0.76
Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care. J Magn Reson Imaging (2017) 0.75
Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis (1976) 6.26
Synthesis of subgenomic mRNA's of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping. J Virol (1981) 2.65
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology (1999) 2.40
Selective paralysis of voluntary but not limbically influenced automatic respiration. Arch Neurol (1991) 2.27
Parental consumption of contaminated sport fish from Lake Ontario and predicted fecundability. Epidemiology (2000) 1.69
Antigenic differences between endozoites and cystozoites of Toxoplasma gondii. J Parasitol (1983) 1.67
Bronchial hyperresponsiveness in normal subjects during attenuated influenza virus infection. Am Rev Respir Dis (1991) 1.64
Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology (1999) 1.59
Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler (2000) 1.54
Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire. Mult Scler (2003) 1.49
Polychlorinated biphenyl serum concentrations, lifestyle and time-to-pregnancy. Hum Reprod (2008) 1.48
MRI findings in 32 consecutive lipomas using conventional and advanced sequences. J Neuroimaging (1999) 1.48
"Normal-pressure" hydrocephalus. Relationship of clinical and radiographic findings to improvement following shunt surgery. JAMA (1976) 1.47
Interferons should be used to treat most patients with MS. Arch Neurol (1998) 1.39
Computerized axial transverse tomography in cerebrovascular disease. Neurology (1976) 1.39
Glycoprotein gE-negative pseudorabies virus has a reduced capability to infect second- and third-order neurons of the olfactory and trigeminal routes in the porcine central nervous system. J Gen Virol (1994) 1.36
Do alcoholics give valid self-reports? J Stud Alcohol (1984) 1.31
Isolation of cadmium-binding proteins. Experientia (1971) 1.30
Decorin interacts with fibrillar collagen of embryonic and adult human skin. J Struct Biol (1991) 1.30
Time course of mental and psychomotor effects of 30 per cent nitrous oxide during inhalation and recovery. Anesthesiology (1981) 1.30
Rationing medical care: rhetoric and reality in the Oregon Health Plan. CMAJ (2001) 1.28
A combined fluorescence histochemical and electron microscopic method for studying special monoamine-containing cells (SIF cells). J Comp Neurol (1974) 1.25
Correlations of nuclear magnetic resonance imaging, computerized tomography, and clinical profiles in multiple sclerosis. Neurology (1986) 1.22
Species difference in carotid body response of cat and dog to dopamine and serotonin. Am J Physiol (1972) 1.21
Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol (2001) 1.21
Differences in Toxoplasma dye test and hemagglutination antibodies shown by antigen fractionation. Am J Trop Med Hyg (1967) 1.20
Changes in size of normal lateral ventricles during aging determined by computerized tomography. Neurology (1976) 1.17
The biosynthesis of metallothionein rat liver and kidney after administration of cadmium. Chem Biol Interact (1976) 1.17
The lesions producing paralysis of downward but not upward gaze. Arch Neurol (1973) 1.16
Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport (2000) 1.15
Toxoplasma and toxoplasmosis. Adv Parasitol (1967) 1.14
Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX. Gene Ther (2006) 1.10
Synthesis of long cDNA from viral RNA template. Gene Anal Tech (1989) 1.10
A population-based study of motorcycle injury and costs. Ann Emerg Med (1992) 1.10
Metabolism of intravenously injected cadmium-binding protein. Biochem Biophys Res Commun (1975) 1.10
Intrathecal interferon reduces exacerbations of multiple sclerosis. Science (1981) 1.10
Palinacousis: persistent or recurring auditory sensations. Cortex (1973) 1.10
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J Neuroimmunol (2001) 1.09
Evaluation of a latex agglutination test for toxoplasmosis. J Parasitol (1967) 1.09
Auditory-visual synesthesia: sound-induced photisms. Arch Neurol (1981) 1.09
A Wallerian degeneration pattern in patients at risk for MS. Neurology (2000) 1.08
Computerized axial transverse tomography in normal pressure hydrocephalus. Neurology (1976) 1.08
Cadmium and zinc binding in mammalian liver and kidneys. Arch Environ Health (1972) 1.08
Intrathecal interferon in multiple sclerosis. Arch Neurol (1982) 1.07
Abdominal aortic aneurysm repair in Veterans Affairs medical centers. J Vasc Surg (1996) 1.07
Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Computed tomographic, nuclear magnetic resonance, and clinical correlations. Arch Neurol (1985) 1.03
Evaluation of mechanism of increased intracranial pressure with insufflation. Surg Endosc (1998) 1.03
Clinical nurse practitioner in a surgical team. Ann R Coll Surg Engl (1995) 1.03
Cadmium and zinc in pregnancy and lactation. Arch Environ Health (1972) 1.02
Silent brain lesions in patients with isolated idiopathic optic neuritis. A clinical and nuclear magnetic resonance imaging study. Arch Neurol (1986) 1.02
Diazepam effects and kinetics in Caucasians and Orientals. Clin Pharmacol Ther (1981) 1.01
Metoprolol in essential tremor. Arch Neurol (1980) 0.99
An eye movement disorder in amyotrophic lateral sclerosis. Neurology (1981) 0.99
MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport (2000) 0.99
The chemical control of biofouling in industrial water systems. Biodegradation (1998) 0.99
Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study. Arch Neurol (1987) 0.99
Visual allesthesia. Neurology (1980) 0.98
Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch Gen Psychiatry (1984) 0.98
Accuracy of fatal motorcycle-injury reporting on death certificates. Accid Anal Prev (1994) 0.98
Stimulation of the carotid chemoreceptors of the dog by dopamine. Proc Natl Acad Sci U S A (1968) 0.97
Lead nephrotoxicity and associated disorders: biochemical mechanisms. Toxicology (1992) 0.97
Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology (1999) 0.97
The vascular endothelium as a target tissue in acute cadmium toxicity. Life Sci (1986) 0.97
Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci (2001) 0.96
Quantification of chemical mutagenesis in diploid human fibroblasts: induction of azaguanine-resistant mutants by N-methyl-N'-nitro-N-nitrosoguanidine. Mutat Res (1978) 0.96
Characterization and translation of transmissible gastroenteritis virus mRNAs. J Virol (1986) 0.96
Reflex apnea, bradycardia, and hypotension produced by serotonin and phenyldiguanide acting on the nodose ganglia of the cat. Circ Res (1971) 0.94
Metallothionein in the extracellular fluids as an index of cadmium toxicity. Environ Health Perspect (1979) 0.93
Differences in cadmium and mercury uptakes by hepatocytes: role of calcium channels. Toxicol Appl Pharmacol (1991) 0.93
Three primitive reflexes in normal adults. Neurology (1980) 0.93
Elevated urinary excretion of metallothionein due to environmental cadmium exposure. Toxicology (1981) 0.93
Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls. J Neuroimmunol (1995) 0.92
Metallothionein in plasma and urine of cadmium-exposed rats determined by a single-antibody radioimmunoassay. Fundam Appl Toxicol (1983) 0.92
Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis. J Clin Immunol (1993) 0.92
Cytotoxicity of cadmium and characteristics of its transport in cardiomyocytes. Toxicol Appl Pharmacol (1999) 0.92
Sex differences in hepatic and renal cadmium accumulation and metallothionein induction. Role of estradiol. Biochem Pharmacol (1991) 0.91
Extracellular microfibrils are increased in localized and systemic scleroderma skin. Lab Invest (1991) 0.91
Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings. J Neuroimaging (2001) 0.91
Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial. J Anxiety Disord (2008) 0.91
Carotid sinus versus carotid body origin of nicotine and cyanide bradycardia in the dog. Am J Physiol (1971) 0.90
The mechanisms of hepatic and renal metallothionein biosynthesis in cadmium-exposed rats. Chem Biol Interact (1977) 0.90
The impact of complications after vascular surgery in Veterans Affairs Medical Centers. J Surg Res (1997) 0.89
Cadmium uptake by primary cultures of rat renal cortical epithelial cells: influence of cell density and other metal ions. Toxicol Appl Pharmacol (1993) 0.89
Spontaneous palpebromandibular synkinesia: a localizing clinical sign. Ann Neurol (1994) 0.89
Toxoplasma cystozoite antigenic change in tissue culture. J Parasitol (1985) 0.89
Additional evidence of autoxidation as a possible mechanism of neutrophil locomotory dysfunction in blunt trauma. Crit Care Med (1990) 0.89
Autopsy correlations of computerized tomography: experience with 6,000 CT scans. Neurology (1976) 0.88
Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis. Lancet (1987) 0.88
Elastin-associated microfibrils (10 nm) in a three-dimensional fibroblast culture. J Invest Dermatol (1991) 0.88
Biological differences in cadmium and zinc turnover. Arch Environ Health (1972) 0.87
Early computed tomography hypodensity predicts hemorrhage after intravenous tissue plasminogen activator in acute ischemic stroke. J Neuroimaging (2001) 0.87
Mechanism controlling sleep organization of the obese Zucker rats. J Appl Physiol (1985) (1998) 0.87
Three primitive reflexes in parkinsonism patients. Neurology (1980) 0.87
Culturing keratinocytes and fibroblasts in a three-dimensional mesh results in epidermal differentiation and formation of a basal lamina-anchoring zone. J Invest Dermatol (1993) 0.87
Metallothionein excretion in urine upon cadmium exposure: its relationship with liver and kidney cadmium. Toxicology (1981) 0.87
Selective hepatic arterial embolization of grade IV and V blunt hepatic injuries: an extension of resuscitation in the nonoperative management of traumatic hepatic injuries. J Trauma (1998) 0.87
Urinary metallothionein and tissue metal levels of rats injected with cadmium, mercury, lead, copper or zinc. Toxicology (1983) 0.86
Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione. Toxicol Appl Pharmacol (1998) 0.86
Diabetes mellitus in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry (1977) 0.86